Kevin L. Winthrop, MD, MPH, Editor

Leonard H. Calabrese, DO, Editor

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

Infection and Malignancy in Rheumatic Diseases Infection and Malignancy in Rheumatic Diseases Vaccines and Disease-Modifying Antirheumatic Drugs Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology Malignancy and Janus Kinase Inhibition The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era

Full access? Get Clinical Tree